News | May 13, 2023
Dr. Lal Path Labs posts Q4 FY23 consolidated PAT at Rs. 56.7 Cr
Dr. Lal Path Labs has reported total income of Rs. 505.2 crores during the period ended March 31, 2023
Dr. Lal Path Labs has reported total income of Rs. 505.2 crores during the period ended March 31, 2023
Alembic has reported total income of Rs. 39.15 crores during the period ended March 31, 2023
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Subscribe To Our Newsletter & Stay Updated
